Semafore Pharmaceuticals
About:
Semafore Pharmaceuticals discovers and develops clinical-stage drugs.
Website: http://www.semaforepharma.com
Top Investors: Twilight Venture Partners
Description:
Semafore Pharmaceuticals is a development-stage drug discovery company that targets the PI3K cell signaling pathways to create anti-cancer drugs. Their PI3K inhibitors are used to treat tumors and have the potential to treat cancers of the brain, lungs, and hemological systems.
Total Funding Amount:
$13.5M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Indianapolis, Indiana, United States
Founded Date:
2000-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2007-01-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai